Literature DB >> 11950031

Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations.

Doruk Erkan1, Evan Leibowitz, Jessica Berman, Michael D Lockshin.   

Abstract

UNLABELLED: Patients with antiphospholipid syndrome (APS), who are predisposed to vascular thrombotic events, are at additional risk for thrombosis when they undergo surgery. Serious perioperative complications (recurrent thrombosis, catastrophic exacerbation, or bleeding) occur despite prophylaxis. We describe our perioperative experience with APS patients who underwent a variety of surgeries, review the literature, and discuss strategies that may guide other physicians in their perioperative evaluation and management of patients with APS. RECOMMENDATIONS: perioperative strategies should be clearly identified before surgical procedure; pharmacological and physical antithrombosis interventions vigorously employed; periods without anticoagulation kept to a minimum; and any deviation from a normal course should be considered a potential disease related event.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11950031

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  18 in total

Review 1.  Perioperative care for patients with rheumatic diseases.

Authors:  Bharath M Akkara Veetil; Tim Bongartz
Journal:  Nat Rev Rheumatol       Date:  2011-11-15       Impact factor: 20.543

2.  Perioperative management of patients with connective tissue disease.

Authors:  Susan M Goodman; Mark P Figgie; C Ronald Mackenzie
Journal:  HSS J       Date:  2010-08-17

3.  Antiphospholipid Antibody Syndrome.

Authors:  Elena Cucurull; Azzudin E. Gharavi; Yamini Menon; Wendell A. Wilson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-04

4.  Antiphospholipid syndrome: a series of surgical emergencies and the current evidence for its management.

Authors:  A E Agaba; N Charaklias; A Babu-Victor; P O Agaba; V Deepchand; H S Dabasia; S S Sharma; M J Goodrick; B Ramanand
Journal:  Ann R Coll Surg Engl       Date:  2006-07       Impact factor: 1.891

Review 5.  Postoperative risk of venous thromboembolism in rheumatic disease patients.

Authors:  Lauren E Wong; Anne R Bass
Journal:  Curr Rheumatol Rep       Date:  2015-02       Impact factor: 4.592

Review 6.  What is antiphospholipid syndrome?

Authors:  Doruk Erkan; Michael D Lockshin
Journal:  Curr Rheumatol Rep       Date:  2004-12       Impact factor: 4.592

Review 7.  Primary thrombosis prophylaxis in antiphospholipid antibody-positive patients: where do we stand?

Authors:  Medha Barbhaiya; Doruk Erkan
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

8.  Long term outcome of catastrophic antiphospholipid syndrome survivors.

Authors:  D Erkan; R A Asherson; G Espinosa; R Cervera; J Font; J-C Piette; M D Lockshin
Journal:  Ann Rheum Dis       Date:  2003-06       Impact factor: 19.103

Review 9.  The Heart and APS.

Authors:  Mary-Carmen Amigo
Journal:  Clin Rev Allergy Immunol       Date:  2007-04       Impact factor: 8.667

Review 10.  Perioperative management of antiphospholipid antibody-positive patients.

Authors:  Katherine H Saunders; Doruk Erkan; Michael D Lockshin
Journal:  Curr Rheumatol Rep       Date:  2014-07       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.